Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tesaro Inc (TSRO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,431,964
  • Shares Outstanding, K 54,910
  • Annual Sales, $ 223,330 K
  • Annual Income, $ -496,130 K
  • 36-Month Beta 1.01
  • Price/Sales 10.67
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -2.62
  • Number of Estimates 11
  • High Estimate -2.19
  • Low Estimate -3.05
  • Prior Year -0.47
  • Growth Rate Est. (year over year) -457.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.75 +20.22%
on 09/19/18
44.98 -4.45%
on 10/17/18
+7.21 (+20.16%)
since 09/18/18
3-Month
25.62 +67.76%
on 08/06/18
44.98 -4.45%
on 10/17/18
+2.02 (+4.93%)
since 07/18/18
52-Week
25.62 +67.76%
on 08/06/18
119.00 -63.88%
on 10/30/17
-70.62 (-62.17%)
since 10/18/17

Most Recent Stories

More News
TESARO to Announce Third-Quarter 2018 Financial Results on November 1, 2018

TESARO, Inc. (NASDAQ: TSRO) will announce third-quarter 2018 financial results on Thursday, November 1, 2018, after the close of the U.S. financial markets. TESARO's senior management team will host a...

TSRO : 42.98 (-2.96%)
42.0% Return Seen to Date on SmarTrend Tesaro Inc Call (TSRO)

SmarTrend identified an Uptrend for Tesaro Inc (NASDAQ:TSRO) on August 22nd, 2018 at $31.27. In approximately 2 months, Tesaro Inc has returned 41.99% as of today's recent price of $44.40.

TSRO : 42.98 (-2.96%)
Shares of Aimmune Therapeu Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (AIMT , TSRO , IONS , ALKS , BMRN )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AIMT : 27.71 (-4.08%)
IONS : 46.35 (-2.09%)
TSRO : 42.98 (-2.96%)
Uptrend Call Working As Tesaro Inc Stock Rises 34.5% (TSRO)

SmarTrend identified an Uptrend for Tesaro Inc (NASDAQ:TSRO) on August 22nd, 2018 at $31.27. In approximately 1 month, Tesaro Inc has returned 34.51% as of today's recent price of $42.06.

TSRO : 42.98 (-2.96%)
Do Options Traders Know Something About Tesaro (TSRO) Stock We Don't?

Investors need to pay close attention to Tesaro (TSRO) stock based on the movements in the options market lately

TSRO : 42.98 (-2.96%)
Today's Research Reports on Trending Tickers: Tesaro and Sarepta Therapeutics

NEW YORK, NY / ACCESSWIRE / October 4, 2018 / Major U.S. markets closed up on Wednesday, with the Dow Jones hitting a record high for the 15th time this year on upbeat economic data. However, market gains...

SRPT : 138.80 (-2.25%)
TSRO : 42.98 (-2.96%)
Tesaro Inc Set to Possibly Pullback After Yesterday's Rally of 3.63%

Tesaro Inc (NASDAQ:TSRO) traded in a range yesterday that spanned from a low of $39.64 to a high of $41.50. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of $40.69...

TSRO : 42.98 (-2.96%)
Clovis' Rubraca Gets Breakthrough Therapy Status for mCRPC

Clovis' (CLVS) cancer drug, Rubraca, gets Breakthrough Therapy designation from the FDA for treating metastatic castration resistant prostate cancer with BRCA mutation.

AZN : 38.95 (-0.87%)
MRK : 72.21 (+0.54%)
CLVS : 29.96 (-4.74%)
TSRO : 42.98 (-2.96%)
Here's Why J&J (JNJ) is a Good Bet in a Troubled Market

A diversified portfolio, robust pipeline, strong growth of new drugs and a consistent dividend payout make Johnson & Johnson (JNJ) a good bet amid market turmoil as well as over the long term.

JNJ : 139.50 (+0.03%)
ABBV : 89.90 (-2.57%)
TSRO : 42.98 (-2.96%)
RHHBY : 29.8350 (+0.12%)
Tesaro Inc Shares Up 22.8% Since SmarTrend's Buy Recommendation (TSRO)

SmarTrend identified an Uptrend for Tesaro Inc (NASDAQ:TSRO) on August 22nd, 2018 at $31.27. In approximately 1 month, Tesaro Inc has returned 22.83% as of today's recent price of $38.41.

TSRO : 42.98 (-2.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade TSRO with:

Business Summary

Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor...

See More

Key Turning Points

2nd Resistance Point 45.09
1st Resistance Point 44.04
Last Price 42.98
1st Support Level 42.35
2nd Support Level 41.72

See More

52-Week High 119.00
Fibonacci 61.8% 83.33
Fibonacci 50% 72.31
Fibonacci 38.2% 61.29
Last Price 42.98
52-Week Low 25.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar